Skip to content
Search

Latest Stories

Pharmacists urged to put on their 'technology forecasting hats'

It's time for pharmacists to get their technology forecasting hats on and be selective in choosing digital technologies, commented Prof James Woudhuysen, of London South Bank University, at the National Pharmacy Association (NPA) Conference, Pharmacy Odyssey, held on Thursday (13 October).

In a session on ‘Healthcare in tomorrow’s digital environment’, hosted by Fergus Walsh, Prof Woudhuysen opined that digitisation has its merit, but it's quite tricky, and slower than we imagine.


“Mechanisation has a digital component that we can look to as a way out of the gloom of the moment. And in dispensing, labelling, prescribing, and many other features of the conventional retail pharmacist, there's a lot that could be done for productivity and automation,” he said.

Replying to a question on ‘where are we at the digital front now and where can it go',  Woudhuysen replied: “It's taken 20 years for the electronic prescription. It was Tony Blair, who wanted every prescription electronic. The mishaps on repeat prescriptions and all the rest of it are still quite intense. So, we need to remember that electronics is only as clever as software and then human input into it. There’re still many mistakes.

“So when I hear about medicines being delivered by drone, I say, that would be a 20-year prospect. If the regulators and popular opinion would allow it.”

He added: “The rule with IT is that it's ‘not seamless’, there's a lot of loose ends, there's a lot of spaghetti. I'm not saying we shouldn't digitise, we should.

“But as is the case with the services that pharmacists are now being asked to add, one must be very selective whether you're choosing an online system and app, which services to offer, very importantly, which services not to offer. So I think it's time for pharmacists to get their technology forecasting hats on, not believe the hype, but look for where it can make a genuine difference.”

Woudhuysen also shared his views on the genomics revolution. He said: “We're just beginning to see with pharmacogenomics, some progress, and at the same time that we also know that there's a lot of silly business done with DNA testing and people being, very nervous about what they found out about their all their congenital defects and so on. So there's a lot of moral and regulatory ground to be fixed, and there's still a lot to be done with the help of IT in personalising medicine.”

“AI techniques are improving machine learning. It is allowing us to learn things that human beings by themselves couldn't learn or not learn so fast. That's good news,” he commented on AI revolution.

He added: “if you look at other developments, you've got also some drugs that are being used for Type II diabetes like they're helpful in relation to dementia, such things have been talked about for 20 years, and a lot has been said about dementia as well. We're just on the cusp of something new. It's still gonna take a number of years for all of these developments, to move ahead.”

Woudhuysen believes that with labor shortages, medicine shortages, inflation, staff burnout, assaults and threats, pharmacists have got enough on their plate, and the issue of carbon footprint must be left to the energy industry to fix itself.

On Walsh’s question on the future of the high streets, Woudhuysen commented they are not going survive in the present form.

“It's the job of pharmacists to kind of lead it, because if they're waiting around for a decrease in business rates, or, the government to make some friendly stipend, there'll be waiting a long time, unless they take action, the future is going to happen to them, rather than they make it happen,” he said.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less